Novel Therapies of Hepatitis B and D

Novel Therapies of Hepatitis B and D

Hepatitis B virus (HBV) infection is a global public health issue and is a major cause of cirrhosis and hepatocellular carcinoma (HCC). Hepatitis D virus (HDV) requires the hepatitis B surface antigen (HBsAg) to replicate. The eradication of HBV, therefore, can also cure HDV. The current therapies f...

Full description

Bibliographic Details
Main Authors: Iman Waheed Khan, Mati Ullah Dad Ullah, Mina Choudhry, Mukarram Jamat Ali, Muhammad Ashar Ali, Sam L. K. Lam, Pir Ahmad Shah, Satinder Pal Kaur, Daryl T. Y. Lau
Format: Article
Language:English
Published: MDPI AG 2021-12-01
Series:Microorganisms
Subjects:
Hepatitis B virus (HBV)
Hepatitis D virus (HDV)
novel therapies
siRNAs
cccDNA inhibitors
capsid assembly modulators
Online Access:https://www.mdpi.com/2076-2607/9/12/2607

Internet

https://www.mdpi.com/2076-2607/9/12/2607

Similar Items